Download PDF

1. Company Snapshot

1.a. Company Description

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally.The company offers diagnostic, therapeutic, and intensive care facilities in a medical center.Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers.


In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business.It operates 580 beds and approximately 56 clinics/centers.The company was founded in 1980 and is headquartered in Bangkok, Thailand.

Show Full description

1.b. Last Insights on BZ7A

Have nothing to say about that one ...

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

Health Care Roundup: Market Talk

Nov -18

Source:

Card image cap

3 Asian Dividend Stocks Yielding Up To 5.5%

Jul -18

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (10.40%)

6. Segments

Hospital and Health Care Center

Expected Growth: 10.4%

Growing demand for quality healthcare, increasing medical tourism, and expansion of healthcare services in Thailand drive growth. Bumrungrad Hospital's reputation for excellence and strategic partnerships also contribute to its growth.

7. Detailed Products

Cardiovascular Services

Bumrungrad Hospital offers a comprehensive range of cardiovascular services, including diagnosis, treatment, and surgery for heart conditions such as coronary artery disease, heart failure, and arrhythmias.

Orthopedic Services

Bumrungrad Hospital provides advanced orthopedic care, including joint replacements, sports medicine, and treatment for musculoskeletal disorders.

Cancer Treatment

Bumrungrad Hospital offers comprehensive cancer treatment, including chemotherapy, radiation therapy, and surgical oncology.

Neurological Services

Bumrungrad Hospital provides advanced neurological care, including diagnosis and treatment of stroke, brain and spinal cord injuries, and neurosurgical procedures.

Organ Transplantation

Bumrungrad Hospital offers organ transplantation services, including kidney, liver, and heart transplants.

Health Check-ups

Bumrungrad Hospital offers comprehensive health check-ups, including routine check-ups, executive check-ups, and specialized check-ups.

Rehabilitation Services

Bumrungrad Hospital provides rehabilitation services, including physical therapy, occupational therapy, and speech therapy.

International Patient Services

Bumrungrad Hospital offers international patient services, including language support, cultural support, and travel arrangements.

8. Bumrungrad Hospital Public Company Limited's Porter Forces

Forces Ranking

Threat Of Substitutes

Bumrungrad Hospital Public Company Limited faces moderate threat from substitutes due to the presence of alternative healthcare providers in Thailand.

Bargaining Power Of Customers

Patients have limited bargaining power due to the specialized nature of medical services and the hospital's reputation for quality care.

Bargaining Power Of Suppliers

Suppliers of medical equipment and pharmaceuticals have moderate bargaining power due to the hospital's dependence on these supplies.

Threat Of New Entrants

The threat of new entrants is low due to the high barriers to entry in the healthcare industry, including regulatory hurdles and significant capital investments required to establish a hospital.

Intensity Of Rivalry

The hospital operates in a highly competitive market with several established players, leading to intense rivalry among healthcare providers in Thailand.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 0.38%
Debt Cost 3.95%
Equity Weight 99.62%
Equity Cost 5.01%
WACC 5.00%
Leverage 0.38%

11. Quality Control: Bumrungrad Hospital Public Company Limited passed 9 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Beximco Pharma

A-Score: 8.5/10

Value: 6.8

Growth: 7.4

Quality: 7.2

Yield: 10.0

Momentum: 9.5

Volatility: 10.0

1-Year Total Return ->

View Full Report
Stock-Card
Encompass Health

A-Score: 5.7/10

Value: 3.8

Growth: 5.1

Quality: 7.0

Yield: 1.0

Momentum: 8.5

Volatility: 8.7

1-Year Total Return ->

View Full Report
Stock-Card
Bumrungrad Hospital

A-Score: 5.5/10

Value: 2.0

Growth: 7.3

Quality: 8.8

Yield: 4.2

Momentum: 1.5

Volatility: 9.3

1-Year Total Return ->

View Full Report
Stock-Card
HUTCHMED

A-Score: 5.5/10

Value: 6.7

Growth: 7.4

Quality: 7.1

Yield: 0.0

Momentum: 4.0

Volatility: 7.7

1-Year Total Return ->

View Full Report
Stock-Card
Tenet Healthcare

A-Score: 5.2/10

Value: 6.3

Growth: 6.8

Quality: 5.5

Yield: 0.0

Momentum: 7.5

Volatility: 5.3

1-Year Total Return ->

View Full Report
Stock-Card
DaVita

A-Score: 4.8/10

Value: 8.2

Growth: 7.0

Quality: 4.8

Yield: 0.0

Momentum: 2.0

Volatility: 7.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

4.12$

Current Price

4.12$

Potential

-0.00%

Expected Cash-Flows